Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-039694
Filing Date
2023-11-21
Accepted
2023-11-21 10:08:50
Documents
17
Period of Report
2023-11-21

Document Format Files

Seq Description Document Type Size
1 6-K a231121_6kxmanifest-2webca.htm 6-K 11529
2 EX-99.1 exhibit_991.htm EX-99.1 16275
3 GRAPHIC exhibit_991001.jpg GRAPHIC 113958
4 GRAPHIC exhibit_991002.jpg GRAPHIC 216224
5 GRAPHIC exhibit_991003.jpg GRAPHIC 89627
6 GRAPHIC exhibit_991004.jpg GRAPHIC 111805
7 GRAPHIC exhibit_991005.jpg GRAPHIC 104589
8 GRAPHIC exhibit_991006.jpg GRAPHIC 84234
9 GRAPHIC exhibit_991007.jpg GRAPHIC 95694
10 GRAPHIC exhibit_991008.jpg GRAPHIC 58904
11 GRAPHIC exhibit_991009.jpg GRAPHIC 87713
12 GRAPHIC exhibit_991010.jpg GRAPHIC 86118
13 GRAPHIC exhibit_991011.jpg GRAPHIC 106290
14 GRAPHIC exhibit_991012.jpg GRAPHIC 111653
15 GRAPHIC exhibit_991013.jpg GRAPHIC 67045
16 GRAPHIC exhibit_991014.jpg GRAPHIC 57788
17 GRAPHIC exhibit_991015.jpg GRAPHIC 80256
  Complete submission text file 0001628280-23-039694.txt   2057624
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231424809
SIC: 2834 Pharmaceutical Preparations